Greece pharmaceutical products over time
US$, annual.
In more detail
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$3.1 billion | 95.1% |
| 3002 Human blood | US$81.5 million | 2.5% |
| 3003 Medicaments | US$35.4 million | 1.1% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$30.5 million | 0.9% |
| 3006 Pharmaceutical goods | US$12.5 million | 0.4% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$693,000 | 0.0% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$2.6 billion | 80.3% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$167.9 million | 5.2% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$98.5 million | 3.0% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$58.7 million | 1.8% |
| 300450 Medicaments: containing vitamins or their derivatives, for therapeutic or prophylactic use, packaged for retail sale | US$49.5 million | 1.5% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$47.4 million | 1.5% |
| 300220 Vaccines: for human medicine | US$47.3 million | 1.5% |
| 300410 Medicaments: containing penicillins, streptomycins or their derivatives, for therapeutic or prophylactic uses, packaged for retail sale | US$30.2 million | 0.9% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$27.3 million | 0.8% |
| 300440 Medicaments: containing alkaloids or their derivatives (but not hormones or antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$27.2 million | 0.8% |
| Heading | Value | Share |
|---|---|---|
| 3004 Medicaments | US$2.7 billion | 64.0% |
| 3002 Human blood | US$1.3 billion | 29.6% |
| 3003 Medicaments | US$125.6 million | 3.0% |
| 3006 Pharmaceutical goods | US$79.9 million | 1.9% |
| 3005 Wadding, gauze, bandages (dressings, adhesive plasters… | US$59.5 million | 1.4% |
| 3001 Glands and other organs (extracts, secretions thereof)… | US$4.9 million | 0.1% |
| Product | Value | Share |
|---|---|---|
| 300490 Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail sale | US$2.2 billion | 53.1% |
| 300290 Toxins, cultures of micro-organisms (excluding yeasts) and similar products | US$962.0 million | 22.7% |
| 300220 Vaccines: for human medicine | US$213.7 million | 5.1% |
| 300439 Medicaments: containing hormones (but not insulin), adrenal cortex hormones or antibiotics, for therapeutic or prophylactic uses, packaged for retail sale | US$134.4 million | 3.2% |
| 300431 Medicaments: containing insulin (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$118.6 million | 2.8% |
| 300390 Medicaments: (not containing antibiotics, hormones, alkaloids or their derivatives), for therapeutic or prophylactic uses, (not packaged for retail sale) | US$114.7 million | 2.7% |
| 300420 Medicaments: containing antibiotics (other than penicillins, streptomycins or their derivatives), for therapeutic or prophylactic uses, packaged for retail sale | US$85.1 million | 2.0% |
| 300432 Medicaments: containing adrenal cortex hormones (but not containing antibiotics), for therapeutic or prophylactic uses, packaged for retail sale | US$62.9 million | 1.5% |
| 300210 Blood: human and animal, antisera and other blood fractions | US$54.4 million | 1.3% |
| 300630 Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient | US$39.7 million | 0.9% |
Shares are of Greece's pharmaceutical products in the same direction. See Pharmaceutical products for all countries or all of Greece's trade.
More Greece products
- 27 Mineral fuels, mineral oils and products of their distillation
- 85 Electrical machinery and equipment and parts thereof
- 84 Machinery and mechanical appliances, boilers, nuclear reactors
- 87 Vehicles
- 39 Plastics and articles thereof
- 76 Aluminium and articles thereof
- 29 Organic chemicals
- 72 Iron and steel
- 02 Meat and edible meat offal
- 20 Preparations of vegetables, fruit, nuts or other parts of plants
- 90 Optical, photographic, cinematographic, measuring, checking, medical or surgical instruments and apparatus
- 04 Dairy produce
Greece pharmaceutical products: questions and answers
How much pharmaceutical products does Greece export?
In 2024, Greece exported US$3.2 billion of pharmaceutical products (HS chapter 30), 6.3% of its total exports. That ranks it 26 of 213 exporting countries in the data.
What are Greece's biggest pharmaceutical products exports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$3.1 billion), Human blood (3002, US$81.5 million), Medicaments (3003, US$35.4 million).
How much pharmaceutical products does Greece import?
In 2024, Greece imported US$4.2 billion of pharmaceutical products (HS chapter 30), 4.6% of its total imports. That ranks it 32 of 226 importing countries in the data.
What are Greece's biggest pharmaceutical products imports?
In 2024, the largest 4-digit headings were Medicaments (3004, US$2.7 billion), Human blood (3002, US$1.3 billion), Medicaments (3003, US$125.6 million).
